Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cell Therapy in Patients With Covid-19 Using Wharton’S Jelly Mesenchymal Stem Cells: A Phase 1 Clinical Trial Publisher Pubmed



Saleh M1 ; Vaezi AA2 ; Aliannejad R3, 4 ; Sohrabpour AA5 ; Kiaei SZF6 ; Shadnoush M7 ; Siavashi V8 ; Aghaghazvini L9 ; Khoundabi B10 ; Abdoli S11 ; Chahardouli B12 ; Seyhoun I1 ; Alijani N13 ; Verdi J1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Internal Medicine, Alborz University of Medical Sciences, Karaj, Iran
  3. 3. Department of Pulmonary and Critical Care, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Advanced Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Associate Professor of Gastroenterology and Hepatology, Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Advanced Thoracic Research Centre, Tehran University of Medical Science, Tehran, Iran
  7. 7. Department of Clinical Nutrition, Faculty of Nutrition & Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  8. 8. Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
  9. 9. Associate Professor, Department of Radiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  10. 10. Iran Helal Institute of Applied-Science and Technology, Research Center for Health Management in Mass Gathering, Red Crescent Society of the Islamic Republic of Iran, Tehran, Iran
  11. 11. Pasteur Institute of Iran, National Cell Bank of Iran, Tehran, Iran
  12. 12. Hematology, Oncology, and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
  13. 13. Department of Infectious Diseases, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Stem Cell Research and Therapy Published:2021


Abstract

Background: Mesenchymal stem cells (MSCs) have received particular attention because of their ability to modulate the immune system and inhibit inflammation caused by cytokine storms due to SARS-CoV-2. New alternative therapies may reduce mortality rates in patients with COVID19. This study aimed to assess the safety and efficacy of injecting intravenous Wharton’s jelly-derived MSCs in patients with COVID-19 as a treatment. Methods: In this study, five patients with severe COVID-19 were treated with Wharton’s jelly-derived mesenchymal stem cells (150 × 106 cells per injection). These patients were subject to three intravenous injections 3 days apart, and monitoring was done on days 0, 3, 6, and 14 in routine tests, inflammatory cytokines, and flow cytometry of CD4 and CD8 markers. A lung CT scan was performed on base and days 14 and 28. In addition, IgM and IgG antibodies against SARS-CoV-2 were measured before and after treatment. Results: The results showed that IL-10 and SDF-1 increased after cell therapy, but VEGF, TGF-β, IFN-γ, IL-6, and TNFα decreased. Routine hematology tests, myocardial enzyme tests, biochemical tests, and inflammation tests were performed for all patients before and after cell therapy on base and days 3, 6, and 14, which indicated the improvement of test results over time. COVID-19 antibody tests rose in 14 days after WJ-MSC injection. The total score of zonal involvement in both lungs was improved. Conclusions: In patients, the trend of tests was generally improving, and we experienced a reduction in inflammation. No serious complications were observed in patients except the headache in one of them, which was resolved without medication. In this study, we found that patients with severe COVID-19 in the inflammatory phase respond better to cell therapy. More extensive clinical trials should be performed in this regard. Trial registration: IRCT, IRCT20190717044241N2. Registered April 22, 2020. © 2021, The Author(s).
Related Docs
View other Related Docs
1. Application of Wharton Jelly-Derived Mesenchymal Stem Cells in Patients With Pulmonary Fibrosis, Stem Cell Research and Therapy (2022)
2. Human Placenta-Derived Mesenchymal Stem Cells Transplantation in Patients With Acute Respiratory Distress Syndrome (Ards) Caused by Covid-19 (Phase I Clinical Trial): Safety Profile Assessment, Stem Cell Research and Therapy (2022)
3. The Role of Mesenchymal Stromal Cells in Immune Modulation of Covid-19: Focus on Cytokine Storm, Stem Cell Research and Therapy (2020)
4. The Critical Role of Mesenchymal Stromal/Stem Cell Therapy in Covid-19 Patients: An Updated Review, Cell Biochemistry and Function (2021)
5. Stem Cell Therapy Potency in Personalizing Severe Covid-19 Treatment, Stem Cell Reviews and Reports (2021)
6. Wharton's Jelly-Mesenchymal Stem Cells Treatment for Severe Covid 19 Patients: 1-Year Follow-Up, Gene Reports (2022)
7. Risk Factors for Adverse Outcomes of Covid-19 Patients: Possible Basis for Diverse Responses to the Novel Coronavirus Sars-Cov-2, Life Sciences (2021)
8. Mesenchymal Stromal/Stem Cells (Mscs) and Msc-Derived Extracellular Vesicles in Covid-19-Induced Ards: Mechanisms of Action, Research Progress, Challenges, and Opportunities, International Immunopharmacology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (27)
Seyed Ahmad Seyed Alinaghi (9)
Other Related Docs
9. The Promising Approach of Mscs Therapy for Covid-19 Treatment, Cell and Tissue Banking (2023)
10. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
11. Mesenchymal Stem Cell Therapies for Covid-19: Current Status and Mechanism of Action, Life Sciences (2020)
12. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
13. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
14. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
15. Safety and Efficacy Study of Allogeneic Human Menstrual Blood Stromal Cells Secretome to Treat Severe Covid-19 Patients: Clinical Trial Phase I & Ii, Stem Cell Research and Therapy (2022)
16. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
17. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)
18. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)
19. Regenerative Medicine in Covid-19 Treatment: Real Opportunities and Range of Promises, Stem Cell Reviews and Reports (2021)
20. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)
21. The Use of Mesenchymal Stem Cells in the Process of Treatment and Tissue Regeneration After Recovery in Patients With Covid-19, Gene (2021)
22. Natural Killer Cells in Covid-19: From Infection, to Vaccination and Therapy, Future Virology (2023)
23. A Review of Covid-19: The Main Ways of Transmission and Some Prevention Solutions, Clinical Symptoms, More Vulnerable Human Groups, Risk Factors, Diagnosis, and Treatment, Journal of Environmental Treatment Techniques (2020)
24. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
25. Covid-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions, Frontiers in Cell and Developmental Biology (2021)
26. Artificial Intelligence and Covid-19: Deep Learning Approaches for Diagnosis and Treatment, IEEE Access (2020)
27. A Review on the Mechanisms Involved in the Immunopathogenesis of Sars-Cov-2, Journal of Military Medicine (2020)
28. Sars-Cov-2 and Acute Cerebrovascular Events: An Overview, Journal of Clinical Medicine (2021)
29. Psycho-Neuroendocrine-Immune Aspects of Covid-19 and Its Relationship With Post-Traumatic Stress Disorder, Current Psychiatry Research and Reviews (2024)
30. Auxiliary Role of Mesenchymal Stem Cells As Regenerative Medicine Soldiers to Attenuate Inflammatory Processes of Severe Acute Respiratory Infections Caused by Covid-19, Cell and Tissue Banking (2020)
31. Genetically Engineered Mesenchymal Stromal Cells As a New Trend for Treatment of Severe Acute Graft-Versus-Host Disease, Clinical and Experimental Immunology (2022)
32. The Association Between Cardiac Injury and Outcomes in Hospitalized Patients With Covid-19, Internal and Emergency Medicine (2020)
33. The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations During the Covid-19 Pandemic, Biomolecules (2021)
34. Intracranial Aneurysm Rupture After Sars-Cov2 Infection: Case Report and Review of Literature, Pathogens (2022)
35. Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami, Inflammopharmacology (2023)
36. Determine the Most Common Clinical Symptoms in Covid-19 Patients: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2020)
37. A Pharmacology-Based Comprehensive Review on Medicinal Plants and Phytoactive Constituents Possibly Effective in the Management of Covid-19, Phytotherapy Research (2021)
38. Structure-Based Study of Immune Receptors As Eligible Binding Targets of Coronavirus Sars-Cov-2 Spike Protein, Journal of Molecular Graphics and Modelling (2021)
39. Diminution of Sting Expression in the Blood of Patients With Severe or Critical Covid-19 Pneumonia, International Archives of Allergy and Immunology (2023)
40. Pathophysiology of Covid-19 Infection: What Is the Novel Coronavirus (Sars-Cov-2) Doing to Body? a Comprehensive Systematic Review, Reviews and Research in Medical Microbiology (2021)
41. The Emerging Role of Micrornas in the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Infection, International Immunopharmacology (2021)
42. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
43. Th17 and Treg Cells Function in Sars-Cov2 Patients Compared With Healthy Controls, Journal of Cellular Physiology (2021)
44. Biomarker Based Biosensors: An Opportunity for Diagnosis of Covid-19, Reviews in Medical Virology (2022)
45. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)
46. Exploring the Causes of Mild Covid-19 Involvement in Pediatric Patients, New Microbes and New Infections (2020)
47. Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives, Frontiers in Cell and Developmental Biology (2021)
48. Potential of Therapeutic Plasmapheresis in Treatment of Covid-19 Patients: Immunopathogenesis and Coagulopathy, Transfusion and Apheresis Science (2020)
49. The Prognostic Value of Comorbidity for the Severity of Covid-19: A Systematic Review and Meta-Analysis Study, PLoS ONE (2021)
50. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)